
INMB
INmune Bio Inc.
$2.03
-$0.06(-2.87%)
18
Overall
--
Value
18
Tech
--
Quality
Market Cap
$57.42M
Volume
541.37K
52W Range
$1.89 - $11.64
Target Price
$9.65
Order:
Income Statement
Metric | Trend | Chart | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
---|---|---|---|---|---|---|---|---|---|
REVENUE | |||||||||
Total Revenue | -- | -- | $11.0K | $181.0K | $374.0K | $155.0K | $14.0K | ||
Total Revenue | -- | -- | $11.0K | $181.0K | $374.0K | $155.0K | $14.0K | ||
GROSS PROFIT | |||||||||
Gross Profit | -- | -- | $11.0K | $181.0K | $374.0K | $155.0K | $14.0K | ||
OPERATING EXPENSES | |||||||||
Operating Expenses | $-12.4M | $7.8M | $12.2M | $29.3M | $26.3M | $29.9M | $42.6M | ||
Research & Development | $3.4M | $3.3M | $5.9M | $20.5M | $17.1M | $20.3M | $33.2M | ||
Research Expense | $3.4M | $3.3M | $5.9M | $20.5M | $17.1M | $20.3M | $33.2M | ||
Selling, General & Administrative | $9.1M | $6.0M | $6.3M | $8.8M | $9.3M | $9.6M | $9.5M | ||
General & Administrative Expenses | $9.1M | $6.0M | $6.3M | $8.8M | $9.3M | $9.6M | $9.5M | ||
Salaries & Wages | $-10.0M | $-4.1M | $3.1M | $4.8M | $1.0M | $7.4M | $7.6M | ||
Other Operating Expenses | -- | $-1.5M | -- | $1.2M | $209.0K | $163.0K | $161.0K | ||
OPERATING INCOME | |||||||||
Operating income | $-12.4M | $-7.8M | $-12.2M | $-29.2M | $-26.0M | $-29.7M | $-42.6M | ||
EBITDA | $-12.4M | $-7.7M | $-12.2M | $-29.2M | $-26.0M | $-34.0M | $-50.1M | ||
NON-OPERATING ITEMS | |||||||||
Interest Expense (Non-Operating) | -- | -- | -- | $985.0K | $2.0M | $2.3M | $789.0K | ||
Intinc | -- | $77.7K | -- | -- | -- | -- | -- | ||
Net Non-Operating Interest Income/Expense | -- | $77.7K | -- | $-985.0K | $-2.0M | $-2.3M | $-789.0K | ||
Other Income/Expense | -- | $-77.7K | $-129.0K | $2.0K | $-1.3M | $267.0K | $-553.0K | ||
Other Special Charges | -- | $77.7K | $129.0K | $-2.0K | $-1.3M | $-267.0K | $553.0K | ||
PRE-TAX INCOME | |||||||||
EBIT | $-12.4M | $-7.7M | $-12.2M | $-29.2M | $-26.0M | $-34.0M | $-50.1M | ||
Pre-Tax Income | $-12.4M | $-7.7M | $-12.1M | $-30.3M | $-27.3M | $-30.0M | $-42.1M | ||
INCOME TAX | |||||||||
Tax Provision | $-71.0K | $159.2K | $-2.5M | $-6.4M | $-5.7M | $-6.3M | $-8.8M | ||
NET INCOME | |||||||||
Net Income | $-12.4M | $-7.7M | $-12.1M | $-30.3M | $-27.3M | $-30.0M | $-42.1M | ||
Net Income (Continuing Operations) | $-12.4M | $-7.7M | $-12.1M | $-30.3M | $-27.3M | $-30.0M | $-42.1M | ||
Net Income (Discontinued Operations) | $-12.4M | $-7.7M | $-12.1M | $-30.3M | $-27.3M | $-30.0M | $-42.1M | ||
Net Income (Common Stockholders) | $-12.4M | $-7.7M | $-12.1M | $-30.3M | $-27.3M | $-30.0M | $-42.1M | ||
Normalized Income | -- | -- | -- | $-36.7M | -- | -- | $-50.9M | ||
TOTALS | |||||||||
Total Expenses | $-12.4M | $7.8M | $12.2M | $29.3M | $26.3M | $29.9M | $42.6M | ||
SHARE & EPS DATA | |||||||||
Average Shares Outstanding | $8.7M | $10.3M | $12.0M | $16.1M | $17.9M | $18.0M | $19.9M | ||
Average Shares Outstanding (Diluted) | $8.7M | $10.3M | $12.0M | -- | $17.9M | $18.0M | $19.9M | ||
Shares Outstanding | $26.6M | $10.7M | $14.9M | $17.9M | $17.9M | $26.6M | $26.6M | ||
Basic EPS | -- | -- | $-1.01 | $-1.88 | $-1.52 | $-1.67 | $-2.11 | ||
Basic EPS (Continuing Operations) | -- | -- | $-1.01 | $-1.88 | $-1.52 | $-1.67 | $-2.11 | ||
Diluted EPS | $-1.43 | $-0.75 | $-1.01 | $-1.88 | $-1.52 | $-1.67 | $-2.11 | ||
Diluted EPS (Continuing Operations) | -- | $-0.75 | -- | -- | $-1.52 | $-1.67 | $-2.11 | ||
OTHER METRICS | |||||||||
Other Gand A | $9.1M | $6.0M | $6.3M | $8.8M | $9.3M | $9.6M | $9.5M | ||
Rent And Landing Fees | $9.1M | -- | -- | -- | -- | -- | -- |
Financial data is updated quarterly and may not reflect the most recent earnings.
A | B | C | D | |
---|---|---|---|---|
1 | Symbol | Price | Change | Vol |
2 | INMB | $2.03 | -2.9% | 541.37K |
3 | ||||
4 | ||||
5 | ||||
6 |